Tnuva logistical center  credit: Rafi Kutz Ministry: Salmonella in Tnuva milk powder poses no health risk

The Ministry of Health has confirmed that salmonella was present in a batch of Tnuva milk powder, but says the product was not sold to the public.

Dr. Elazar Sonnenschein with Pulsenmore product  credit: Pulsenmore Strategic agreement with GE Healthcare boosts Pulsenmore

GE Healthcare will invest up to $50 million in the Israeli home ultrasound devices company and will distribute pregnancy monitoring products.

Cancer Personalized cancer therapy co OncoHost raises $35m

The Israeli company's precision oncology diagnostic solution is expected to launch commercially in the US in the third quarter of 2022.

Copaxone Israel sues Teva for $100m Copaxone royalties

The state claims that Teva violated IP rights in the development of the longer interval dosage version of the multiple sclerosis drug.

Nir Altschuler Photo: Eyal Izhar Elron warns Cartiheal acquisition by Bioventus at risk

Bioventus has announced that it has canceled the $415 million it planned to raise to finance the acquisition, due to market conditions.

Digital health  / Photo: Shutterstock Incontinence treatment co BlueWind Medical raises $64m

The Israeli company has developed the RENOVA iStim implantable tibial neuromodulation device under investigation for the treatment of incontinence and overactive bladder (OAB).

Ben Gurion airport Photo: Shlomi Yosef Covid testing on entering Israel to end

Israel will stop requiring passengers landing at Ben Gurion airport and entering Israel to undergo PCR testing from Friday, May 20, the Health Ministry has announced.

Assaf Barnea Credit: Alon Ron Sanara sets up $100m VC fund to transform healthcare

The Israeli healthcare investment platform has already raised half of the sum with Philips Healthcare as lead investor.

Imagene AI founders Credit: Kfir Ziv AI cancer medicine co Imagene AI raises $21.5m

Imagene's digitized biopsy image AI diagnostic technology delivers real-time molecular analysis, increasing the level of accuracy and reducing the time required for results, from several weeks to just two minutes.

Kare Schultz  credit: Shlomi Yosef Teva meets profit expectations but misses on revenue

The Israeli pharmaceutical company has cut 2022 revenue guidance.

Hello Heart Michal Gutmann, Maayan Cohen and Ziv Meltzer Credit: PR Hello Heart Heart disease management co Hello Heart raises $70m

The Israeli company's heart disease management system identifies high blood pressure, excessive cholesterol and other phenomena associated with heart disease.

Matricelf produces in-house induced pluripotent stem cells

The ability to independently produce iPSC’s, in parallel to the completion of the hydrogel development, is a crucial step towards end-to-end independent manufacturing capacity of neural tissue implants.

Dr. Julian Adams Creditr: PR Gamida Cell jumps on FDA lymphoma treatment clearance

GDA-201 is an off-the-shelf cell therapy candidate for the treatment of patients with follicular and diffuse large B cell lymphomas.

The lean startup myth  credit: Gil Gibli The lean Israeli startup is a thing of the past

Set-up costs are soaring, and conditions at the multinationals are just too good.

Mask wearing Credit: Shlomi Yosef Israel to end mask mandate Saturday night

With new Covid infections on the wane, the requirement to wear masks in enclosed spaces will be canceled from Saturday night, April 23, at 8pm.

Teva  credit: Shutterstock FDA delays approval for Teva schizophrenia drug

Teva and its French partner MedinCell have received a Complete Response Letter, meaning that the New Drug Application cannot be approved in its present form.

Ben Gurion Airport duty free Credit: Cadya Levy Israel footing bill for Covid positive foreign tourists

Israeli government policy is that foreign tourists who test positive for Covid must be accommodated in a government-run Covid hotel.

Yossi Ofek Photo: Eyal Izhar Teva targets sub-Saharan Africa

Teva VP Ukraine, Africa, and Middle East Yossi Ofek, who also manages Teva Israel, explains why Teva has launched operations in countries global pharma companies avoid, and insists Teva remains committed to Israel.

Biotech  credit: Shutterstock angellodeco Nano Dotz teams with Greek co TheraCell

The companies will collaborate on a project using Dotz Nano's technology for marking disposable bioprocessing consumables.

Prof. Zeev Rotstein  credit: Eyal Izhar Securities Authority halts drug co EPM's offering via television

EPM front man Prof. Zeev Rotstein: Apparently we managed to annoy someone.

Eytan Stibbe   credit: Ori Burg Israeli astronaut Eytan Stibbe reaches Int'l Space Station

Businessman and former Air Force pilot Stibbe is part of the first commercial space mission by Axiom Space.

Digital health  / Photo: Shutterstock LionBird closes $85m digital health VC fund

To date LionBird has invested in more than 30 digital health companies.

Chris Mansi and David Golan Photo: PR AI disease detection co raises $100m at $1.2b valuation

The company has pioneered the use of AI algorithms and machine learning to increase the speed of diagnosis and care for a variety of diseases in hospitals and health systems.

Orit Farkash-Hacohen credit: Cadya Levy Gov't proposes new tax breaks for early-stage tech investors

The cost of the measures to the taxpayer is estimated at NIS 320 million over four years.

Nir Altschuler Photo: Eyal Izhar $500m CartiHeal sale to go ahead after FDA approval granted

US orthologics company Bioventus is acquiring the Israeli cartilage implants company for $350 million, plus $150 million from future revenue.

Teva  credit: Shutterstock Teva agrees opioid settlement with Florida

Teva will pay Florida $177 million over 15 years and provide opioid overdose treatments worth $84 million over 10 years.

Naftali Bennett  credit: Marc Israel Sellem, Jerusalem Post Prime minister tests positive for Covid-19

It is not yet known whether Prime Minister Naftali Bennett will make his planned official visit to India at the end of the week.

Covid vaccination MDA Spokesperson 4th Covid vaccination cuts morbidity and death, studies find

Studies by the Clalit and Maccabi health funds have found that four vaccine doses give considerably better protection than three.

NTT head office in Tokyo  credit: Shutterstock-Morumotto Giant Japanese telco NTT scouting Israeli digital health tech

The company has set up NTT Innovation Laboratory Israel to collaborate with local startups and academic institutions.

Nucleai CEO Avi Veidman Photo: David Garb Israeli AI precision oncology co Nucleai raises $33m

Nucleai is an AI-powered spatial biology company, which seeks to transform drug development and clinical treatment decisions through pathology data.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018